There are many screening programmes designed to identify pregnancies at inc
reased risk of aneuploidy, in particular Down syndrome. Serum biochemical a
nd ultrasound screening in the first and second trimester may further confu
se risk interpretation when used in unselected populations. This article re
views current Down syndrome screening programmes, their advantages and limi
tations, and possible areas for research.